It is now clear that the mast cell's functional response to IgE-dependent s
timulation can be Influenced significantly by the level of expression of th
e high-affinity IgE receptor (Fc epsilon RI) on the cell's surface. Thus, m
odulation of Fc epsilon RI surface expression represents a potentially impo
rtant mechanism for regulating mast cell activity in allergic reactions. In
this study, we examined whether a glucocorticoid, dexamethasone (DEX), can
influence levels of mast cell Fc epsilon RI expression either in the prese
nce or absence of IgE, an up-regulator of the mast cell surface Fc epsilon
RI level. In the absence of IgE, DEX decreased the surface Fc epsilon RI le
vels in mouse peritoneal mast cells, mouse bone marrow-derived cultured mas
t cells and a mouse mast cell line, CI.MC/C57.1. Moreover, DEX also partial
ly suppressed the ability of IgE to enhance surface expression of FceRI in
these cells. Three different glucocorticoids, DEX, methylprednisolone and h
ydrocortisone, suppressed FceRI expression in mast cells, whereas sex stero
ids, i.e. estradiol, progesterone and testosterone, did not, indicating tha
t the Fc epsilon RI-suppressing effect is glucocorticoid specific. On the o
ther hand, DEX did not affect levels of Fc epsilon RI alpha, beta or gamma
mRNA, suggesting that its ability to decrease surface Fc epsilon RI reflect
s a post-transcriptional mechanism. Finally, DEX-treated mast cells showed
a reduced degranulation response to antigenic stimulation through down-regu
lation of surface Fc epsilon RI expression in addition to DEX-induced chang
es in downstream signals. These results show that mast cell surface Fc epsi
lon RI expression is suppressed by glucocorticoids in both the presence and
absence of IgE, and suggest that reduction of mast cell surface Fc epsilon
RI levels may be one of the favorable anti-allergic actions of glucocortic
oids.